Thomas is a Partner at Ysios Capital, where he focuses on early-stage life sciences investments across Europe. Before joining the firm, he was a Senior Associate at Gimv’s Health & Care team in Antwerp. During his time at Gimv, he co-led investments in Anjarium Biosciences and Kinaset Therapeutics, and contributed to the development of portfolio companies including Fire1, ONWARD (Euronext: ONWD), Biotalys (Euronext: BTLS), JenaValve (acquired by Edwards), and Breath Therapeutics (acquired by Zambon). He holds Master’s degrees in Bioengineering and Applied Economics from the University of Ghent. Thomas currently serves on the boards of Tagworks Pharmaceuticals, Memo Therapeutics, and Anaconda Biomed.